Veterinary Medicines

Nafpenzal DC (300 mg + 100 mg + 100 mg)/3 g Maść dowymieniowa

Authorised
  • Dihydrostreptomycin sulfate
  • Nafcillin sodium monohydrate
  • Benzylpenicillin procaine
Download as PDF

Product identification

Medicine name:
Nafpenzal DC (300 mg + 100 mg + 100 mg)/3 g Maść dowymieniowa
Active substance:
  • Dihydrostreptomycin sulfate
  • Nafcillin sodium monohydrate
  • Benzylpenicillin procaine
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Dihydrostreptomycin sulfate
    100.00
    milligram(s)
    /
    3.00
    gram(s)
  • Nafcillin sodium monohydrate
    100.00
    milligram(s)
    /
    3.00
    gram(s)
  • Benzylpenicillin procaine
    300.00
    milligram(s)
    /
    1.00
    milligram(s)
Pharmaceutical form:
  • Intramammary ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        5
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC23
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0688
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."